Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model

Kara Rossfeld,Steven E. Justiniano,Haiming Ding,Li Gong,Shankaran Kothandaraman,Dwitiya Sawant,Motoyasu Saji,Chadwick Wright,Lawrence S. Kirschner,Matthew D. Ringel,Michael F. Tweedle,John E. Phay

Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model

2017

Kara Rossfeld
Steven E. Justiniano
Haiming Ding
Li Gong
Shankaran Kothandaraman
Dwitiya Sawant
Motoyasu Saji
Chadwick Wright
Lawrence S. Kirschner
Matthew D. Ringel
Michael F. Tweedle
John E. Phay

Context: The primary and definitive treatment of medullary thyroid cancer (MTC) is surgical resection. Recurrent or residual disease is typically a result of incomplete surgical removal.

Keywords:

Endocrinology
Internal medicine
Medullary thyroid cancer
Imaging agent
Medicine
surgical removal
Cancer
In vitro
fluorescent imaging
In vivo
biological evaluation
surgical resection

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations